Interestingly, as shown in Figure 4, treatment of MCF-7 cells with the selective estrogen-receptor modulator (SERM) tamoxifen caused repression of Hes-6, indicating that Hes-6 might work as a marker for tamoxifen response in breast cancer cells. This evidence concerns the gene HES6 and breast cancer.